Jubilant Pharmova (BOM:530019) Other Net Income (Loss) : ₹0 Mil (TTM As of Mar. 2024)

View and export this data going back to 1995. Start your Free Trial

What is Jubilant Pharmova Other Net Income (Loss)?

Jubilant Pharmova's Other Net Income (Loss) for the three months ended in Mar. 2024 was ₹0 Mil. Its Other Net Income (Loss) for the trailing twelve months (TTM) ended in Mar. 2024 was ₹0 Mil.

Jubilant Pharmova Other Net Income (Loss) Historical Data

The historical data trend for Jubilant Pharmova's Other Net Income (Loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jubilant Pharmova Other Net Income (Loss) Chart

Jubilant Pharmova Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Other Net Income (Loss)

Get a 7-Day Free Trial

2,204.71

2,617.53

Jubilant Pharmova Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Net Income (Loss)	Get a 7-Day Free Trial															-	-	-	-	-

Jubilant Pharmova Other Net Income (Loss) Calculation

Different companies can and do choose to report each of income statement items separately. Yet, there are a variety of items which are simply too numerous to list. Therefore GuruFocus uses a standardized financial statement format for all companies. Other Net Income (Loss) may include but is not limited to items such as net income (loss) from discontinuing operations, extraordinary, earnings from equity interest net of tax, etc. After-tax income and Other Net Income (Loss) together constitute Net Income Including Noncontrolling Interests.

Other Net Income (Loss) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.

Jubilant Pharmova Other Net Income (Loss) Related Terms

Thank you for viewing the detailed overview of Jubilant Pharmova's Other Net Income (Loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

Jubilant Pharmova (BOM:530019) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jubilant Pharmova Ltd (BOM:530019) » Definitions » Other Net Income (Loss)

Traded in Other Exchanges

JUBLPHARMA:India

Address

1A, Sector 16A, Noida, UP, IND, 201 301

Website

https://www.jubilantpharmova.com

Jubilant Pharmova Ltd is an integrated global pharmaceutical company. The company's segment includes Radiopharma; Allergy Immunotherapy; Contract Development and Manufacturing Organisation - Sterile Injectables; Generics; Contract Research, Development and Manufacturing Organisation and Proprietary Novel Drugs. It generates maximum revenue from the Radiopharma segment. Geographically, it derives a majority of its revenue from Americas and Europe.

Jubilant Pharmova (BOM:530019) Headlines

No Headlines